Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.


HHS - 1961 - National Institute of Allergy and Infectious Diseases Special Emphasis Panel - Authorized by Law
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameNational Institute of Allergy and Infectious Diseases Special Emphasis PanelAgency NameDepartment of Health and Human Services
Fiscal Year2020Committee Number1961
Original Establishment Date9/30/1994Committee StatusChartered
Actual Termination Date Committee URL 
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*Unlimited
Current Charter Date9/30/1994Designated Fed Officer Position Title*Director, Scientific Review Program
Date Of Renewal Charter Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*Jay
Exempt From Renewal*YesDesignated Federal Officer Middle NameR.
Specific Termination AuthorityDesignated Federal Officer Last Name*Radke
Establishment Authority*Authorized by LawDesignated Federal Officer SuffixPHD
Specific Establishment Authority*42 USC 282(b)(16)Designated Federal Officer Phone*(301) 761-6616
Effective Date Of Authority*11/20/1985Designated Federal Officer Fax*301-402-2638
Exempt From EO 13875 Discretionary CmteExempt: Merit Review PanelDesignated Federal Officer Email*jay.radke@nih.gov
Committee Type*Continuing
Presidential*No
Committee Function*Special Emphasis Panel
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*This committee is composed entirely of recognized biomedical and/or behavioral research authorities who represent the forefront of research and technical knowledge and who provide first-level merit review of highly scientific and technical research grant applications and contract proposals in the fields of immunology, immunobiology, immunologic and allergic diseases, transplantation, microbiology and infectious diseases, mycology, virology, epidemiology, drug development and synthesis, therapeutics research, tropical diseases, sexually transmitted diseases, vaccinology, AIDS and AIDS-related research. Operation of this committee is accomplished using a fluid membership, with members designated to serve for individual meetings rather than formally appointed for fixed terms of service. The reviewers for each meeting are selected to evaluate grant applications and/or contract proposals for a specific, perhaps narrow, expertise area. Participants for each meeting are assembled to most efficiently and effectively cover the number and breadth of applications or contracts requiring review. During this reporting period the committee reviewed 1935 grant and cooperative agreement applications requesting $4,822,477,461 in direct costs. In addition the committee reviewed 114 contract proposals requesting total direct costs of $553,178,350.00 for all years.
How is membership balanced?*This committee has a fluid membership, with members designated to serve for individual meetings rather than formally appointed for fixed terms of service. The reviewers for each meeting are selected to evaluate grant applications or contract proposals for a specific, perhaps narrow, expertise area. Participants for each meeting are assembled to most efficiently and effectively cover the number and breadth of applications or contracts requiring review.
How frequent & relevant are cmte mtgs?*The NIAID Special Emphasis Panel held 154 meetings during this period. The flexibility in review allowed by this committee structure has proved both efficient and effective.
Why advice can't be obtained elsewhere?*This committee is composed entirely of recognized biomedical and/or behavioral research authorities who represent the forefront of research and technical knowledge and who provide first-level merit review of highly scientific and technical research grant applications and contract proposals. These evaluations and recommendations cannot be obtained from other sources because the specialized, complex nature of the applications and proposals requires a unique balance and breadth of expertise not available on the NIH staff or from other established sources.
Why close or partially close meetings?The meetings of the NIAID Special Emphasis Panel were closed to the public for the review of grant applications and/or contract proposals. Sections 552b(c)(4) and 552(c)(6) of the Government in the Sunshine Act permits the closing of meetings where discussion could reveal confidential trade secrets or commercial property such as patentable material and personal information, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Recommendation RemarksReports: This committee did not produce any public reports during the fiscal year.

URL: The committee does not maintain a website.

The DFO and the Decision Maker are the samer person, the Director, SRP, NIAID based on the assignment of duties within this Institute.

Due to the larger number of members serving on this committee, NIH staff are unable to provide additional information on Occupation or Affiliation. Additional information on an individual’s affiliation may be obtained by contacting the designated federal officer listed in this report.

Zip Codes: Due to the large number of members associated with this committee, NIH staff are unable to provide individual zip codes for all members. Current individual meeting rosters, including zip codes are available on line at https://public.era.nih.gov/pubroster/.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*No
Outcome Trust In GovernmentNoAction Reallocate ResourcesNo
Outcome Major Policy ChangesNoAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingYesAction Approved Grants Or Other PaymentsYes
Outcome Improved Service DeliveryNoAction OtherNo
Outcome Increased Customer SatisfactionNoAction CommentAn action of “approved” or “recommended” for grants receiving initial peer review by this committee does not infer that the grant will be or has been funded. Research grant applications submitted to NIH must go through a two-step review process that includes the initial peer review for scientific and technical merit and a second step of review and approval by a National Advisory Council for program relevance. In addition, prior to an award or funding being made, NIH staff must conduct an administrative review for a number of other considerations. These include alignment with NIH’s funding principles, review of the project budget, assessment of the applicant’s management systems, determination of applicant eligibility, and compliance with public policy requirements. After all these steps have been completed, NIH officials make funding decisions on individual grant applications.
Outcome Implement Laws/Reg RequirementsNoGrants Review*Yes
Outcome OtherNoNumber Of Grants Reviewed1,935
Outcome CommentNANumber Of Grants Recommended1,935
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$4,822,477,461.00
Cost Savings CommentNIH supported basic and clinical accomplishments often take many years to unfold into new diagnostic tests and new ways to treat and prevent diseasesGrants Review CommentNA
Number Of Recommendations*20,565Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentGrant and contract proposals.Access Agency WebsiteYes
% of Recs Fully Implemented*0.00%Access Committee WebsiteNo
% of Recs Fully Implemented CommentNIH Peer Review Committees are involved in the initial review of research grant applications. The NIH dual peer review system is mandated by statute in accordance with section 492 of the Public Health Service Act. The charge to this committee is to determine scientific and technical merit of the individual grants or contracts. These recommendations are forwarded to Federal officials who generally accept the committee’s recommendations and favorable applications are then forwarded for the second level of review performed by Institute and Center (IC) National Advisory Councils or Boards. Only applications that are favorably recommended by both the initial peer review committee and the Advisory Council may be recommended for funding.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*0.00%Access PublicationsNo
% of Recs Partially Implemented CommentNIH Peer Review Committees are involved in the initial review of research grant applications. The NIH dual peer review system is mandated by statute in accordance with section 492 of the Public Health Service Act. The charge to this committee is to determine scientific and technical merit of the individual grants or contracts. These recommendations are forwarded to Federal officials who generally accept the committee’s recommendations and favorable applications are then forwarded for the second level of review performed by Institute and Center (IC) National Advisory Councils or Boards. Only applications that are favorably recommended by both the initial peer review committee and the Advisory Council may be recommended for funding.Access OtherYes
Agency Feedback*YesAccess CommentContact IC Committee Management Officer. 240-669-5201
Agency Feedback Comment*The agency provides written and oral reports.Narrative Description*The National Institute of Allergy and Infectious Diseases Special Emphasis Panel (Panel) reviews grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in the broad areas of allergic and immunologic diseases and disorders, transplantation, vaccinology, microbiology and infectious diseases, including tropical diseases, AIDS and AIDS-related research.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$492,200.00Est Payments to Non-Fed Members Next FY*$492,200.00
Payments to Federal Members* Est. Payments to Fed Members Next FY* 
Payments to Federal Staff*$6,708,242.00Estimated Payments to Federal Staff*$6,741,387.00
Payments to Consultants* Est. Payments to Consultants Next FY* 
Travel Reimb. For Non-Federal Members*$296,795.00Est Travel Reimb Non-Fed Members nextFY*$300,021.00
Travel Reimb. For Federal Members* Est Travel Reimb For Fed Members* 
Travel Reimb. For Federal Staff* Est. Travel Reimb to Fed Staff Next FY* 
Travel Reimb. For Consultants* Est Travel Reimb to Consultants Next FY* 
Other Costs$84,070.00Est. Other Costs Next FY*$85,751.00
Total Costs$7,581,307.00Est. Total Next FY*$7,619,359.00
Federal Staff Support (FTE)*38.60Est. Fed Staff Support Next FY*37.90
Cost RemarksCosts are lower than FY19 due to decrease in Federal staff support. Additionally, due to the COVID-19 pandemic, FY2020 meetings held after March 12, 2020 were virtual only, which reduced committee operating costs. If face to face meetings resume, committee costs for FY2021 may be higher.Est Cost Remarks
Hide Section - Interest Areas

Interest Areas

Category
Area
Health
Health Care
Medicine
Health and Health Research
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-036634National Institute of Allergy and Infectious Diseases Special Emphasis Panel2019
 COM-034847National Institute of Allergy and Infectious Diseases Special Emphasis Panel2018
 COM-001742National Institute of Allergy and Infectious Diseases Special Emphasis Panel2017
 COM-002598National Institute of Allergy and Infectious Diseases Special Emphasis Panel2016
 COM-004140National Institute of Allergy and Infectious Diseases Special Emphasis Panel2015
 COM-004484National Institute of Allergy and Infectious Diseases Special Emphasis Panel2014
 COM-005854National Institute of Allergy and Infectious Diseases Special Emphasis Panel2013
 COM-006499National Institute of Allergy and Infectious Diseases Special Emphasis Panel2012
 COM-008332National Institute of Allergy and Infectious Diseases Special Emphasis Panel2011
 COM-008774National Institute of Allergy and Infectious Diseases Special Emphasis Panel2010
 COM-010417National Institute of Allergy and Infectious Diseases Special Emphasis Panel2009
 COM-010777National Institute of Allergy and Infectious Diseases Special Emphasis Panel2008
 COM-011976National Institute of Allergy and Infectious Diseases Special Emphasis Panel2007
 COM-012621National Institute of Allergy and Infectious Diseases Special Emphasis Panel2006
 COM-014058National Institute of Allergy and Infectious Diseases Special Emphasis Panel2005
 COM-014798National Institute of Allergy and Infectious Diseases Special Emphasis Panel2004
 COM-015904National Institute of Allergy and Infectious Diseases Special Emphasis Panel2003
 COM-016795National Institute of Allergy and Infectious Diseases Special Emphasis Panel2002
 COM-017650National Institute of Allergy and Infectious Diseases Special Emphasis Panel2001
 COM-018372National Institute of Allergy and Infectious Diseases Special Emphasis Panel2000
 COM-019593National Institute of Allergy and Infectious Diseases Special Emphasis Panel1999
 COM-020358National Institute of Allergy and Infectious Diseases Special Emphasis Panel1998
 COM-021487National Institute of Allergy and Infectious Diseases Special Emphasis Panel1997